ICD-10 Code L42: Pityriasis rosea diagnosis and billing guide

Key Takeaways

ICD-10 Code L42 is the billable, terminal diagnostic code for pityriasis rosea, a self-limiting papulosquamous skin disorder of unknown origin.

L42 falls under the L40-L45 Papulosquamous disorders block in Chapter 12 (L00-L99) of ICD-10-CM and has no subcodes.

Synonyms include pityriasis rosea and pityriasis rosea-like drug eruption; accurate differential diagnosis from L40 (psoriasis) and L43 (lichen planus) is critical to avoid claim errors.

Pabau’s claims management software helps dermatology and general practice teams submit L42 encounters accurately and reduce coding-related denials.

ICD-10 code L42 is the billable diagnostic code for pityriasis rosea, a self-limiting papulosquamous skin disorder of unknown cause. It sits in the L40-L45 block of Chapter 12 and is a terminal code, so no additional digits are needed to bill it.

This guide covers L42’s clinical description, recognized synonyms, related and differential codes, the ICD-9-CM crosswalk, and the documentation that supports a clean claim.

ICD-10 Code L42: Definition and clinical description

Pityriasis rosea is a mild, self-limiting exanthem that typically resolves within six to ten weeks. Dermatology EMR software that captures the diagnosis code accurately at the point of documentation keeps L42 claims clean.

ICD-10 Code L42 is the billable, specific ICD-10-CM diagnosis code for pityriasis rosea, effective for dates of service on or after October 1, 2015. The 2026 ICD-10-CM edition (valid from October 1, 2025) confirms L42 remains current with no revisions. It is a terminal code, meaning there are no subcategories or child codes beneath it.

Clinically, pityriasis rosea is a mild exanthematous inflammation of unknown etiology. It presents as salmon-colored maculopapular lesions, typically distributed across the trunk in a “Christmas tree” pattern following skin cleavage lines. A herald patch, an isolated oval plaque appearing one to two weeks before the generalized eruption, is the condition’s most recognizable early feature.

According to the Centers for Medicare and Medicaid Services (CMS), ICD-10-CM codes require a date of service on or after October 1, 2015 to be used for reimbursement purposes. L42 satisfies this requirement and is accepted across all major US payers.

Synonyms and inclusions for L42

Two synonyms are officially recognized under L42 in ICD-10-CM. Understanding both is important because either may appear in clinical documentation or referral letters.

• Pityriasis rosea: The primary clinical term, describing the idiopathic self-limiting exanthem.
• Pityriasis rosea-like drug eruption: A morphologically similar reaction triggered by certain medications, including ACE inhibitors, gold compounds, and some antivirals. Clinically identical in appearance but drug-induced in origin.

When a drug-induced eruption is clearly documented in the chart, some coding professionals debate whether a separate external cause code should accompany L42. The safest approach: follow payer-specific guidance and consult CMS Official Guidelines for Coding and Reporting. Document the suspected causative agent in the clinical note to support the encounter record.

Where L42 sits in the papulosquamous disorders hierarchy

L42 belongs to the L40-L45 Papulosquamous disorders block, itself within Chapter 12 (Diseases of the skin and subcutaneous tissue, L00-L99). Knowing the block structure matters for coders who need to navigate the tabular list or verify crosswalks. The full set of codes in this block includes:

• L40: Psoriasis (multiple subcodes including L40.0-L40.9)
• L41: Parapsoriasis (multiple subcodes)
• L42: Pityriasis rosea (terminal billable code)
• L43: Lichen planus (multiple subcodes)
• L44: Other papulosquamous disorders
• L45: Papulosquamous disorders in diseases classified elsewhere

This hierarchy is defined by the World Health Organization’s ICD-10 browser, which forms the basis for the US ICD-10-CM adaptation maintained by CMS and the National Center for Health Statistics (NCHS).

Because L42 sits directly adjacent to psoriasis (L40) and lichen planus (L43), coders should pay close attention to clinical documentation before assigning any of these codes. Payers audit this block with some frequency given the overlapping presentations.

Differential diagnosis coding: Distinguishing L42 from related codes

Pityriasis rosea shares clinical features with several other papulosquamous and infectious conditions. Assigning the wrong code here creates claim accuracy problems and can trigger audits.

Secondary syphilis is the most clinically consequential differential to exclude. The rash can mimic pityriasis rosea closely, including the distribution pattern. A rapid plasma reagin (RPR) or VDRL test clears this differential when clinical suspicion exists. Documenting the negative serology in the chart protects the L42 assignment on audit.

Guttate psoriasis (L40.4) is the other common point of confusion, particularly in younger patients presenting after a streptococcal throat infection. The absence of a herald patch and the distinct lesion morphology (silvery scale vs. the collarette scale of pityriasis rosea) guide differentiation.

Documentation tips for differential coding

• State the positive clinical features of pityriasis rosea in the note (herald patch present, Christmas tree distribution, self-limiting course expected).
• Document any conditions explicitly ruled out (e.g., “secondary syphilis excluded by negative RPR”).
• If drug-induced eruption is suspected, list the medication and onset timeline relative to drug initiation.
• Use structured templates for skin examination to capture lesion morphology consistently. Digital intake forms built into practice management software ensure no fields are missed at intake.

Streamline dermatology coding and documentation

Pabau's claims management tools and customizable clinical forms help dermatology and general practice teams document L42 encounters accurately, reduce denials, and keep patient records audit-ready.

Book a demo

ICD-9-CM crosswalk for L42

Practices migrating historical encounter data or working with legacy records need to understand the crosswalk between ICD-9-CM and ICD-10-CM. L42 maps directly to a single ICD-9-CM predecessor with no ambiguity.

This is a one-to-one crosswalk. Unlike many dermatology codes where a single ICD-9 code expands into multiple ICD-10 subcodes, pityriasis rosea has no subcategorization in either system. Historical encounters coded as 696.3 translate cleanly to L42 for any data migration or crosswalk analysis.

For practices using a coding lookup tool, the AAPC Codify ICD-10-CM lookup provides searchable crosswalk data alongside official tabular list references, code history, synonyms, and coding notes.

Billing and reimbursement guidance for L42

L42 is a straightforward code from a payer coverage standpoint. No Type 1 or Type 2 Excludes notes apply to L42 in the ICD-10-CM Tabular List. There are no instructional notes requiring additional codes to be sequenced first or secondary. This makes L42 one of the cleaner diagnostic codes to submit in dermatology billing.

CPT codes commonly paired with L42

L42 supports medical necessity for a range of evaluation and management and dermatology procedure codes. The specific CPT code must reflect what was documented and performed during the encounter.

• 99202-99215: Office or outpatient E/M visit codes, new or established patient. Level selection based on medical decision-making or total time documented.
• 99212-99214: Most pityriasis rosea encounters in established patients fall in this range. A straightforward new onset with typical features and reassurance counseling commonly supports 99212 or 99213.
• 96910: Photochemotherapy (tar and ultraviolet B / Goeckerman) for extensive or symptomatic cases requiring phototherapy.
• 11102: Tangential biopsy of skin lesion, single, when tissue diagnosis is needed to exclude other conditions.

Using claims management software that validates code pairings before submission significantly reduces the likelihood of a medical necessity denial on L42 encounters. Practices managing a high volume of dermatology claims benefit from automation that flags unsupported CPT-ICD combinations before they leave the practice.

Reimbursement notes and common denial patterns

Pityriasis rosea encounters are low-complexity from a payer perspective. Denials on L42 claims most often stem from three sources.

• E/M level mismatch: Submitting a level-4 or level-5 E/M code for what the documentation supports as a straightforward rash evaluation. The clinical note must support the selected level.
• Procedure code not matching diagnosis: Pairing a dermatology procedure code with L42 when the note does not document the procedure was performed.
• Drug-induced eruption with no external cause code: Some payers request an additional Y or X code when documentation clearly attributes the rash to a medication. Check payer-specific LCD or coverage determination guidance.

For skin clinic software users, setting up encounter templates specific to pityriasis rosea presentations ensures that all documentation touchpoints (lesion description, distribution, herald patch status, medications reviewed) are captured consistently. This directly supports E/M level selection and reduces denial risk.

Documenting pityriasis rosea encounters in clinical practice

Strong documentation is the foundation of a defensible L42 claim. Every encounter note should address the following elements to support the diagnosis code and the selected E/M level.

Essential documentation elements

• Chief complaint and symptom onset: Duration of the rash, any prodromal symptoms (fatigue, headache, low-grade fever) that preceded the eruption.
• Herald patch description: Presence or absence, size, location, time since appearance.
• Lesion characteristics: Color (salmon/pink), morphology (oval macules or papules), scale type (collarette), distribution pattern (trunk, Christmas tree along Langer’s lines).
• Differentials considered and excluded: Secondary syphilis serology if performed, fungal prep if tinea was in the differential, psoriasis family history if guttate was considered.
• Medication review: Current medications, any recent additions that could explain a drug-induced pityriasis rosea-like eruption.
• Plan and counseling provided: Reassurance about self-limiting course, any symptomatic treatment prescribed, follow-up criteria.

Using AI-powered clinical documentation tools can accelerate note completion without sacrificing specificity. When a clinician describes findings verbally and the system structures the note automatically, documentation completeness improves and coding accuracy follows.

Practices focused on skin assessments can also reference standardized skin assessment tools to create consistent dermatological examination templates. Consistent templates reduce variation in how findings are described, making coding decisions more straightforward.

Telehealth documentation considerations

Pityriasis rosea is visually diagnosable in many cases, making it suitable for telehealth assessment when image quality is adequate. For telehealth encounters using L42, documentation must specify that the clinician visually assessed the lesion morphology and distribution via secure video. The encounter note should match the telehealth-specific E/M code selected. For an overview of telehealth compliance frameworks in practice settings, telehealth in primary care covers the core requirements.

A patient record management system that links intake forms, clinical notes, and billing codes within one encounter record captures the details whose absence most commonly leads to claim scrutiny on dermatology diagnoses.

Conclusion

Claim errors on L42 encounters almost always trace back to the same root cause: documentation that does not reflect the specificity the code requires. Getting pityriasis rosea coding right means noting the herald patch, documenting differentials excluded, and matching the E/M level to what the note actually supports.

Pabau’s claims management software helps dermatology and general practice teams validate code pairings before submission, build diagnosis-specific encounter templates, and maintain audit-ready patient records. To see how Pabau handles dermatology documentation workflows end to end, book a demo.

Frequently Asked Questions